SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

AstraZeneca Pharma India to launch Osimertinib Tablet in India

30 May 2017 Evaluate

AstraZeneca Pharma India has received import and market permission in Form 45 (Marketing Authorization) from the Drug Controller General of India for Osimertinib Tablet 40 mg and 80 mg. The receipt of this import and market permission paves way for the launch of Osimertinib Tablets (Tagrisso TM) in India, subject to the receipt of other related statutory approvals and licenses.

Osimertinib (Tagrisso TM) is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an appropriate test, whose disease has progressed on or after EGFR TKI therapy. Osimertinib (Tagrisso TM) is the first-in-class oral medication for advanced EFGR T790M mutation positive Non-Small Cell Lung Cancer.

Osimertinib (Tagrisso TM) is the product of AstraZeneca group and has been approved in over 45 countries, including US, EU, Japan, China and other Asian countries.


Astrazeneca Pharma I Share Price

8508.80 -16.30 (-0.19%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×